Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of administration of AFQ056 in combination
with L-dopa, in reducing the number of L-dopa related dyskinesias in Parkinson's disease
patients.